EPIDERMAL GROWTH FACTOR RECEPTOR FAMILY MEMBERS (EGFR AND HER2) ARE PROGNOSTIC MARKERS AND POTENTIAL THERAPEUTIC TARGETS IN PROSTATE CANCER